Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1997-02-20
2000-01-04
Reeves, Julie
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303873, 5303882, 53038815, 53038873, 5303896, 5303879, 4241331, 4241391, 4241421, 4241441, 4241531, 4241731, 4241721, 435 724, 435 696, 435 697, 435 7021, 435328, 435331, 435332, 435334, 4353431, A61K 39395, C12N 512, C12N 522, C07K 1628
Patent
active
060111380
ABSTRACT:
Anti-human CD23 monoclonal antibodies containing human gamma 1 constant domains and therapeutic uses are provided. These antibodies inhibit IL-4 induced IgE production by B-cells significantly greater than antibodies containing other constant domains.
REFERENCES:
patent: 4940782 (1990-07-01), Rup et al.
patent: 5585089 (1996-12-01), Queen et al.
Groves et al Hybridoma vol. 6(1) 71, 1987.
Robbins Pathologic Basis of Disease p. 197, 1994.
Seaver Genetic Engineering vol. 14(14) pp. 10 and 21, 1994.
Haak-Frendscho et al Immunology 82:306, 1994.
Delespesse et al Immunology Today 10:159, 1989.
Paul et al Fundamental Immunology Third Edition Chapter 21 Proinflammatory Cytokines and Immunity p. 826, 1993.
Vercelli et al J Exp Med 169:1295, Apr. 1989.
Presta et al J Immunology 151(5) 2623, Sep. 1993.
Strike et al J Immunol 132(4) 1798, Apr. 1984.
Cruse et al Illustrated Dictionary of Immunology CRC Press p. 69, 1995.
Capon et al Nature vol. 337:525, Feb. 1989.
Rector et al., Immunol., 55: 481-488 (1985).
Seumura et al., J. Immunol., 137: 1214-1220 (1986).
Noro et al., J. Immunol., 137: 1258-1263 (1986).
Bonnefoy et al., J. Immunol., 138: 2970-2978 (1987).
Flores-Romo et al., Science, 261: 1038-1046 (1993).
Sherr et al., J. Immunol., 142: 481-489 (1989).
Pene et al., Proc. Natl. Acad. Sci., USA, 85: 6880-6884 (1988).
Bonnefoy et al., Eur. J. Immunol 20: 139-144 (1990).
Sarfati et al., J. Immunol 141: 2195-2199 (1988).
Wakai et al., Hybridoma 12: 25-43 (1993).
Yu et al., Nature 369: 753-756 (1994).
Saxon et al., J. Immunol., 147: 4000-4006 (1991).
D'Ambrosio et al., Science, 268: 293-297 (1995).
Lecoanet et al., Immunol., 88: 35-39 (1996).
Bonnefoy et al., Int. Amer. Allergy Immunol., 107: 40-42 (1995).
Aubry et al., Nature, 358: 505-507 (1992).
Aubry et al., Immunol., 5: 944-949 (1993).
Bonnefoy et al., Curr. Opin. Eur. J. Immunol., 24: 2982-2988 (1994).
Nambu et al., Immunol. Lett., 44: 163-167 (1995).
Sarfati et al., Immunol., 53: 197-205 (1984).
Pene et al., J. Cell Biochem., 39: 253-269 (1989).
Pene et al., J. Immunol., 18: 929-935 (1988).
Saxon et al., J. Allergy, Clin. Immunol. 86 (3 pt 1) 333-344 (1990).
Sarfati et al., Immunol., 76: 662-667 (1992).
Angal et al., Mol. Immunol., 30: 105-108 (1993).
Hassner and Saxon, J. Immunol., 132: 2844 (1984).
Carroll et al., J. Immunol. Methods 89: 61 (1986).
Boerner et al., J. Immunol., 147: 86 (1991).
Lus H et al 1991 J. Immunol 146: 2122-2129.
Kloetzer William S.
Nakamura Takehiko
Reff Mitchell E.
Idec Pharmaceuticals Corporation
Reeves Julie
Seikagaku Corporation
LandOfFree
Gamma-1 anti-human CD23 monoclonal antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gamma-1 anti-human CD23 monoclonal antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gamma-1 anti-human CD23 monoclonal antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1073492